Who owns Halozyme Therapeutics (HALO)? Superinvestor holders

5 superinvestors of the 157 tracked here hold Halozyme Therapeutics (HALO) in their latest 13F filing, with $656.1M between them. Josef Lakonishok gives it the most weight: 0.31% of the reported portfolio. In their latest reported quarter, George Soros opened a position; Josef Lakonishok and John Overdeck and David Siegel (founders) added; Ray Dalio (founder) and Joel Greenblatt reduced.

Ken Fisher and Richard Pzena sold out of it in their latest quarter.

Hold it now
5
of 157 tracked
Combined value
$656.1M
Bought / sold
3 / 4
last quarter

Key facts

Superinvestors holding it
5 of 157
Biggest holder
John Overdeck and David Siegel (founders), $388.5M
Largest weight
Josef Lakonishok, 0.31%of their portfolio
Combined value
$656.1M
Bought last quarter
3
Sold last quarter
4

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding HALO, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Josef LakonishokLSV Asset Management0.31%$166.4M1.51M▲ Added 6.9%+96.88KQ3 2026
2John Overdeck and David Siegel (founders)Two Sigma Investments0.28%$388.5M3.52M▲ Added 113%+1.87MQ3 2026
3Ray Dalio (founder)Bridgewater Associates0.15%$36.3M463.15K▼ Reduced 9.4%−48.28KQ2 2026
4Joel GreenblattGotham Asset Management0.14%$57.9M739.27K▼ Reduced 1.0%−7.54KQ2 2026
5George SorosSoros Fund Management0.11%$7.1M64.12KNew+64.12KQ3 2026

Sold out last quarter

Quarter by quarter

Superinvestor ownership of HALO by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 20269235.09M$562M32
Q2 202615731.21M$94.4M02
Q1 202615721.26M$81.3M12
Q4 20251571561.58K$37.8M10
Q3 202515744.41M$323.3M40
Q2 20251570——00
Q1 20251560——00
Q4 20241560——00

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of HALO held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
John Overdeck and David Siegel (founders)3.52M———————
Josef Lakonishok1.51M———1.27M———
George Soros64.12K———————
Joel Greenblatt·739.27K746.84K—————
Ray Dalio (founder)·463.15K511.43K561.58K487.08K———
Richard Pzena—4.05K——4.11K———
David Shaw (founder)·———2.65M———

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own HALO?

In their latest 13F filings: Josef Lakonishok (0.31% of the portfolio, $166.4M), John Overdeck and David Siegel (founders) (0.28% of the portfolio, $388.5M), Ray Dalio (founder) (0.15% of the portfolio, $36.3M), Joel Greenblatt (0.14% of the portfolio, $57.9M), George Soros (0.11% of the portfolio, $7.1M).

Who bought HALO last quarter?

Josef Lakonishok (added 6.9%), John Overdeck and David Siegel (founders) (added 113%), George Soros (new position). “Last quarter” is each investor's latest reported quarter.

Who sold HALO last quarter?

Reduced: Ray Dalio (founder) (9.4% fewer shares), Joel Greenblatt (1.0% fewer shares). Sold out entirely: Ken Fisher (was $33.5M), Richard Pzena (was $316.9K).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Halozyme Therapeutics (HALO)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/HALO/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to HALO by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.